Home / Brands / Primus Pharmaceuticals
Primus Pharmaceuticals Recalls
4 recalls on record · February 21, 2018 to February 21, 2018 · Drugs
February 21, 2018DrugsFDA
Primus Pharmaceuticals, Inc. recalls Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for
Hazard: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.
February 21, 2018DrugsFDA
Primus Pharmaceuticals, Inc. recalls Limbrel250 (flavocoxid and citrated zinc bisglycinate) 250 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured fo
Hazard: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.
February 21, 2018DrugsFDA
Primus Pharmaceuticals, Inc. recalls Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsda
Hazard: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.
February 21, 2018DrugsFDA
Primus Pharmaceuticals, Inc. recalls Limbrel (flavocoxid 250 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsda
Hazard: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.